Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a body”

255 pharma patents match "The Regents of the University of Colorado, a body" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 255
Index total 30,257
Page 5 / 11

Quick answer

This filtered view shows 255 pharmaceutical patents matching "The Regents of the University of Colorado, a body" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

255 results for “The Regents of the University of Colorado, a body” · 30,257 patents in full index Clear search

  1. US 10519423

    High efficiency reprogramming of fibroblasts into cardiomyocytes

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  2. US 10512672

    Methods for the treatment of inflammatory joint disease

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  3. US 10512687

    Compositions and methods for enhanced innate immunity

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  4. US 10508122

    Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  5. US 10488416

    Targeting breast cancer therapy based on stromal subtypes and CD146 composition

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  6. US 10478508

    Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  7. US 10456448

    PTD-SMAD7 therapeutics

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  8. US 10428126

    Dermaseptin-type and piscidin-type antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  9. US 10428082

    Triazole derivatives of melampomagnolide B and methods of use thereof

    The Regents of the University of Colorado, a body · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  10. US 10420813

    Competitive inhibitors of invariant chain expression and/or ectopic clip binding

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  11. US 10413603

    Compositions, methods and uses for improved human papilloma virus constructs

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  12. US 10413620

    Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  13. US 10407484

    Compositions and methods for modulating T-cell mediated immune response

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  14. US 10406214

    Propionyl-CoA carboxylase compositions and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  15. US 10383939

    Light-activated compositions and methods using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  16. US 10363288

    Insulin mimotopes and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  17. US 10350265

    Therapeutic applications of Smad7

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  18. US 10307437

    Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  19. US 10300107

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 28, 2019 · Expires May 23, 2039

    granted

  20. US 10280415

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

    granted

  21. US 10278986

    Antibody-siRNA conjugates and uses therefor

    The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

    granted

  22. US 10265387

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  23. US 10258606

    Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  24. US 10253024

    Polycyclic indoline and indolenine compounds

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.